{"source": "Twitter for iPhone", "reply_settings": "everyone", "id": "1269505652264755200", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "lang": "en", "in_reply_to_user_id": "2225226474", "conversation_id": "1269347960325890049", "created_at": "2020-06-07T05:45:08.000Z", "possibly_sensitive": false, "referenced_tweets": [{"type": "replied_to", "id": "1269363628488220674"}], "author_id": "931571402", "text": "@88549439 Actually, long QT risk related to plasma concentration. RECOVERY trial loading regime designed to reach the IC50 for SARS-CoV-2 from in vitro studies rapidly, but chronic HCQ treatment for, say, rheumatoid reaches these concentrations but much more slowly.", "entities": {"mentions": [{"start": 0, "end": 9, "username": "88549439", "id": "2225226474"}]}, "public_metrics": {"retweet_count": 0, "reply_count": 3, "like_count": 0, "quote_count": 0}}